CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 140 filers reported holding CHINA BIOLOGIC PRODS INC in Q4 2016. The put-call ratio across all filers is 1.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $16,057,000 | -27.7% | 141,966 | -36.0% | 0.01% | -27.3% |
| Q1 2017 | $22,200,000 | +18.1% | 221,758 | +26.8% | 0.01% | +10.0% |
| Q4 2016 | $18,804,000 | -21.8% | 174,877 | -9.5% | 0.01% | -23.1% |
| Q3 2016 | $24,048,000 | +19.1% | 193,172 | +1.8% | 0.01% | +8.3% |
| Q2 2016 | $20,183,000 | +240.4% | 189,841 | +266.3% | 0.01% | +200.0% |
| Q1 2016 | $5,930,000 | +20.8% | 51,821 | +50.5% | 0.00% | +33.3% |
| Q4 2015 | $4,907,000 | -81.5% | 34,441 | -88.4% | 0.00% | -81.2% |
| Q3 2015 | $26,561,000 | +53.7% | 295,687 | +97.1% | 0.02% | +60.0% |
| Q2 2015 | $17,280,000 | +223.1% | 150,050 | +167.8% | 0.01% | +233.3% |
| Q1 2015 | $5,348,000 | +26.4% | 56,041 | -10.9% | 0.00% | +50.0% |
| Q4 2014 | $4,230,000 | +10.5% | 62,916 | -11.3% | 0.00% | 0.0% |
| Q3 2014 | $3,828,000 | +43.5% | 70,939 | +18.2% | 0.00% | 0.0% |
| Q2 2014 | $2,668,000 | – | 60,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Segantii Capital Management Ltd | 50,000 | $5,288,000 | 5.80% |
| RUDMAN ERROL M | 37,001 | $3,934,000 | 3.76% |
| INDUS CAPITAL PARTNERS, LLC | 349,210 | $37,128,000 | 3.60% |
| WARBURG PINCUS LLC | 1,312,200 | $139,513,000 | 3.04% |
| SPQ Asia Capital Ltd | 96,000 | $10,206,000 | 2.63% |
| OBERWEIS ASSET MANAGEMENT INC/ | 82,775 | $8,801,000 | 2.62% |
| Ativo Capital Management LLC | 94,074 | $10,002,000 | 2.44% |
| Sensato Investors LLC | 99,764 | $10,607,000 | 1.72% |
| Cormorant Asset Management, LP | 112,867 | $12,000,000 | 1.70% |
| BARING ASSET MANAGEMENT Ltd | 131,284 | $13,958,000 | 1.14% |